Fabrinet (NYSE:FN | FN Price Prediction) has risen 250.64% over the past year, climbing from $174.02 to $610.18. If you watched that move from the sidelines, the question now is obvious: has the opportunity passed, or is there still a case for buying in?
Valuation: Premium Multiple, Supported by Growth
At $610.18, Fabrinet trades at a trailing P/E of 53x. That is a premium multiple, and it is fair to acknowledge that upfront. The forward P/E stands at 13x on forward earnings. That gap reflects how fast earnings are actually growing. Revenue in the most recent quarter hit $1.13 billion, up 35.9% year over year, and non-GAAP EPS of $3.36 beat consensus by 3.38%. The PEG ratio sits at 1.19 — not cheap, but not the kind of stretched reading that signals a bubble. The analyst consensus target of $582.22, with 9 Buy ratings and 1 Hold, suggests the Street still sees the stock as fairly valued or modestly undervalued at current levels, even after the run.
Forward Catalyst: The Growth Engine Is Accelerating
The more compelling argument for Fabrinet at this price is that revenue growth is accelerating. Growth went from 19.17% in Q3 FY2025 to 35.9% in Q2 FY2026 — the fastest year-over-year growth since the company’s IPO. Three specific catalysts are driving this.
First, the high-performance computing segment contributed $86 million in Q2, up from $15 million in Q1, tied to a new relationship with Amazon Web Services. CFO Csaba Sverha stated the HPC program is “on track to be fully ramped over the next two quarters.” CEO Seamus Grady indicated the program is expected to reach “north of about $150 million when it is fully ramped.”
Second, data center interconnect demand is proving durable. Grady described it as “very, very strong” with demand that “looks to be very durable.” Third, co-packaged optics programs are live with three separate customers, and optical circuit switching represents an additional emerging revenue category. Q3 FY2026 guidance calls for revenue of $1.15 billion to $1.20 billion with non-GAAP EPS of $3.45 to $3.60. The next earnings report is expected May 6, 2026, giving investors a near-term catalyst check-in.
Risk and Entry: The Downside Is Real
Buying here carries meaningful risk, and retirement-focused investors will want to weigh the risk profile carefully. Free cash flow turned negative at -$5.35 million in Q2 as capital expenditures surged 135.65% year over year to fund capacity expansion. Total liabilities rose 54.96% year over year. Insider activity is also worth noting: CEO Grady sold 22,451 shares in a single day in late November 2025 at prices between $445 and $448, and director Thomas Kelly sold additional shares in February 2026 at $622 to $625. The stock currently sits 8% below its 52-week high of $632.99, meaning there is limited cushion before new lows are set. The 247 Wall St. price model’s base case projects a -25.54% return over the next year, driven primarily by valuation compression risk at the current implied P/E.
Verdict
Fabrinet’s underlying growth drivers (HPC ramp, DCI demand, co-packaged optics, and a 2-million-square-foot facility coming online by end of 2026) are real and still expanding, which is the basis for the investment case at current prices. The forward P/E of 13x on accelerating earnings is not stretched for a company growing revenue at 35.9%. The risks are genuine — negative free cash flow, rising liabilities, and insider selling are not signals to ignore, but they reflect investment in future capacity rather than deteriorating fundamentals. For a retirement-focused investor, the valuation warrants a conservative position size. The May 6 earnings report will be the next data point to assess whether the growth trajectory justifies adding to a position.